Form 4: Health Catalyst CFO Sells Shares to Cover Tax Obligations from RSU Vesting

Health Catalyst, Inc.'s Chief Financial Officer, Jason Alger, sold 2,712 shares of common stock on June 2, 2025, to satisfy tax withholding obligations related to the vesting of Restricted Stock Units.

Summary

• Jason Alger, the Chief Financial Officer of Health Catalyst, Inc. (HCAT), reported a transaction on June 2, 2025.
• The transaction involved the disposition of 2,712 shares of Health Catalyst Common Stock.
• The shares were sold at a price of $3.6348 per share.
• This sale was a 'sell to cover' transaction, mandated by the Issuer's equity incentive plans to satisfy tax withholding obligations upon the vesting of Restricted Stock Units.
• The transaction does not represent a discretionary trade by Mr. Alger.
• Following this transaction, Jason Alger beneficially owns 269,646 shares of Health Catalyst Common Stock directly.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While an insider sale can sometimes be perceived negatively, the explicit explanation that it was a non-discretionary 'sell to cover' transaction for tax purposes mitigates any negative implications, making it a routine and expected event.

Positives

• The transaction indicates the vesting of Restricted Stock Units (RSUs) for the CFO, which is a form of compensation and retention for key management.

Negatives

• The sale of shares by an insider, even if non-discretionary, reduces their direct ownership stake in the company.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• The sale of shares by the Reporting Person was required to cover tax withholding obligations in connection with the vesting of the Issuer's Restricted Stock Units.
• This 'sell to cover' transaction was mandated by the Issuer's election under its equity incentive plans and does not represent a discretionary trade by the Reporting Person.

Industry Context

This specific Form 4 filing details an individual insider transaction and does not provide information relevant to broader industry trends or competitive dynamics within the healthcare analytics or technology sectors.

Stakeholder Impact

• Shareholders: The sale represents a minor dilution of ownership for tax purposes, which is a common and expected occurrence with RSU vesting. It does not signal a change in management's confidence in the company.

Key Dates

Keywords

Health Catalyst, HCAT, Form 4, Insider Transaction, Jason Alger, Chief Financial Officer, Restricted Stock Units, RSU Vesting, Tax Withholding, Sell to Cover